You'll see fewer patients getting prescriptions for the antidepressant Serzone

You'll see fewer patients getting prescriptions for the antidepressant Serzone...due to concerns about liver toxicity.

Bristol-Myers Squibb just pulled it off the market in Europe.

Health Canada and the FDA issued warnings just last year.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote